Tonix Pharmaceuticals (TNXP) is scheduled to report Q1 earnings on May 11, 2026. Analysts estimate EPS of $-2.06 and quarterly revenue of $5.93M.

In the most recent quarter (Q4), Tonix Pharmaceuticals reported EPS of $-3.98, missing estimates of $-3.03 by 0.31%. Revenue came in at $5.39M, exceeding the estimate of $2.93M by 0.84%.

Tonix Pharmaceuticals has missed EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, Tonix Pharmaceuticals has averaged an EPS surprise of 0.30% and a revenue surprise of 0.38%.